EugeneSomozaMD

Clinical Trials

• Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 Start of enrollment: 1996 Nov 01

  Completed

  Phase 2

• Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2 Start of enrollment: 1996 Nov 01

  Completed

  Phase 1

• Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 Start of enrollment: 1998 Sep 01

  Completed

  Phase 2

• Cocaine-Methylphendidate Interaction Study - 4 Start of enrollment: 1997 Dec 01

  Completed

  Phase 1

• Naltrexone in Treatment of Cocaine Dependence - 5 Start of enrollment: 1995 May 01

  Completed

  Phase 2

• Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7 Start of enrollment: 1997 Nov 01

  Completed

  Phase 2

• Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9 Start of enrollment: 1999 Mar 01

  Completed

  Phase 2

• Reserpine for the Treatment of Cocaine Dependence - 1 Start of enrollment: 2001 Jul 01

  Completed

  Phase 2

• Tiagabine for the Treatment of Cocaine Dependence - 1 Start of enrollment: 2002 Oct 01

  Completed

  Phase 2

• Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH) Start of enrollment: 2008 Jan 01

  Completed

  Phase 1

• Vigabatrin for Treatment of Cocaine Dependence Start of enrollment: 2008 Jan 01

  Completed

  Phase 2

• Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy Start of enrollment: 2016 Aug 01

  Completed

  Not Applicable

• Join now to see all